Nao Muraoka, Takuya Oyakawa, Ayano Fujita, Kei Iida, Tomoya Yokota, Hirotsugu Kenmotsu. Frequency of ischemic cardiac events in patients receiving long-term multikinase inhibitor: A report of three cases. Asia-Pacific Journal of Oncology Nursing. 2025. 12. 100624-100624
Yuichi Ozawa, Nobuyuki Yamamoto, Kouji Yamamoto, Kentaro Ito, Hirotsugu Kenmotsu, Hidetoshi Hayashi, Takehito Shukuya, Daichi Fujimoto, Shunichi Sugawara, Seiji Niho, et al. Creation of an Integrated Clinical Trial Database and Data Sharing for Conducting New Research by the Japan Lung Cancer Society. JTO clinical and research reports. 2022. 3. 5. 100317-100317
Ono A, Isaka M, Serizawa M, Omae K, Kojima H, Nakashima K, Omori S, Wakuda K, Kenmotsu H, Naito T, et al. Corrigendum to "Genetic alterations of driver genes as independent prognostic factors for disease-free survival in patients with resected non-small cell lung cancer" [Lung Cancer 128 (2019) 152-157]. Lung cancer (Amsterdam, Netherlands). 2019. 130. 226-226
Norimitsu Kasahara, Hirotsugu Kenmotsu, Masakuni Serizawa, Rina Umehara, Akira Ono, Kazushige Wakuda, Shota Omori, Kazuhisa Nakashima, Tetsuhiko Taira, Tateaki Naito, et al. Plasma epidermal growth factor receptor mutation (EGFR) testing in advanced non-small-cell lung cancer patients harboring EGFR mutations by chip-based digital PCR system. CANCER RESEARCH. 2016. 76
Hirotsugu Kenmotsu, Yusuke Tanigawara. Pharmacokinetics, dynamics and toxicity of docetaxel: Why the Japanese dose differs from the Western dose. CANCER SCIENCE. 2015. 106. 5. 497-504
Hisao Imai, Keita Mori, Akira Ono, Hiroaki Akamatsu, Takehito Shukuya, Tetsuhiko Taira, Hirotsugu Kenmotsu, Tateaki Naito, Haruyasu Murakami, Masahiro Endo, et al. RELATIONSHIP OF PROGRESSION-FREE SURVIVAL, POST-PROGRESSION SURVIVAL AND RESPONSE WITH OVERALL SURVIVAL IN ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER OF INDIVIDUAL-LEVEL. RESPIROLOGY. 2013. 18. 85-85
